CD4+ T-Cells Drive Triple Negative Breast Cancer Recurrence via Non-Canonical TGFβ Signaling
Mayeaux, M. A.; Altman, B. P.; Hacker, B. C.; Alves, S. M.; Jiang, D.; Koong, A. C.; Graves, E. E.; Rafat, M.
Show abstract
Radiation therapy is a cornerstone of breast cancer treatment and reduces recurrence overall. However, patients with triple negative breast cancer (TNBC) continue to experience recurrence at higher rates than patients with other subtypes, especially when immunocompromised. While CD8 T-cells are known to mitigate recurrence, the role of CD4+ T-cell subsets in shaping the irradiated microenvironment remains unclear. We show that irradiated mammary tissue from mice accumulates CD4+ T-cells and exhibits a TGF{beta}-enriched cytokine milieu coincident with macrophage infiltration. We demonstrate that Th2-polarized CD4+ T-cells promote invasion of TNBC cells and macrophages through secretion of TGF{beta}. Neutralization of TGF{beta} significantly reduces this invasive phenotype. Mechanistically, Th2-conditioned media induces Tgfb1 expression in both TNBC cells and macrophages, establishing a TGF{beta}-dependent feed-forward amplification loop. In TNBC cells, Th2-derived TGF{beta} activates non-canonical signaling characterized by increased p38 MAPK and NF-{kappa}B phosphorylation, linking cytokine exposure to pro-invasive behavior. Together, these findings identify Th2-derived TGF{beta} as a driver of pro-invasive tumor reprogramming and suggest that interruption of Th2-TGF{beta} signaling may prevent recurrence following therapy.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogs 91%
- Clinical Validation of Digital PCR-based ctDNA detection for risk stratification in residual triple negative breast cancer: TRICIA trial results 91%
- Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors 90%
Similar papers in this journal
- CXCR3-expressing metastasis-initiating cells induce and exploit a fibroblast niche in the lungs to fuel metastatic colonization 95%
- NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancer 95%
- Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 93%
Similar papers in this journal
- Lineage plasticity enables low-ER luminal tumors to evolve and gain basal-like traits 93%
- Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapy 93%
- Immune gene expression profiling reveals heterogeneity in luminal breast tumors 92%
Similar papers in this journal
- Progesterone receptors drive advanced breast cancer phenotypes including circulating tumor- and stem-like cell expansion in the context of ESR1 mutation 94%
- HIF-1 regulated TPM3 links hypoxia to motility and invasion beyond the hypoxic fraction in triple-negative breast cancer 94%
- The clinical and molecular significance associated with STING signaling in estrogen receptor-positive early breast cancer 92%
Similar papers in this journal
- Hormonal regulation of Semaphorin 7a in ER+ breast cancer drives therapeutic resistance 92%
- IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma 92%
- CIP2A interacts with TopBP1 and is selectively essential for DNA damage-induced basal-like breast cancer tumorigenesis 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.